Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zev A Binder

Showing results (21-30 of 70) with videos related to

Pageof 7
Sort By:
Neuro-Oncology|September 20, 2022
EGFR, the Lazarus target for precision oncology in glioblastomaBenjamin Lin, Julia Ziebro, Erin Smithberger, et al.
Nature Cancer|February 5, 2022
Targeting PAK4 to reprogram the vascular microenvironment and improve CAR-T immunotherapy for glioblastomaWenjuan Ma, Yanling Wang, Rongxin Zhang, et al.
Scientific Reports|March 25, 2018
Radiomic MRI signature reveals three distinct subtypes of glioblastoma with different clinical and molecular characteristics, offering prognostic value beyond IDH1Saima Rathore, Hamed Akbari, Martin Rozycki, et al.
Molecular Therapy Oncolytics|December 2, 2022
The IAP antagonist birinapant enhances chimeric antigen receptor T cell therapy for glioblastoma by overcoming antigen heterogeneityEdward Z Song, Xin Wang, Benjamin I Philipson, et al.
Research in Veterinary Science|December 31, 2020
Pathology of macrophage activation syndrome in humanized NSGS miceJames C Tarrant, Zev A Binder, Mattia Bugatti, et al.
Journal of Neuro-Oncology|September 23, 2019
Negative prognostic impact of epidermal growth factor receptor copy number gain in young adults with isocitrate dehydrogenase wild-type glioblastomaDaniel I Hoffman, Kalil G Abdullah, Makayla McCoskey, et al.
Cancer Immunology Research|May 4, 2022
Immunologic Features in De Novo and Recurrent Glioblastoma Are Associated with Survival OutcomesCécile Alanio, Zev A Binder, Renee B Chang, et al.
Science Translational Medicine|February 28, 2020
Wnt-mediated endothelial transformation into mesenchymal stem cell-like cells induces chemoresistance in glioblastomaMenggui Huang, Duo Zhang, Janet Y Wu, et al.
SLAS Technology|October 6, 2018
Mutation Profiles in Glioblastoma 3D Oncospheres Modulate Drug EfficacyKelli M Wilson, Lesley A Mathews-Griner, Tara Williamson, et al.
Academic Pathology|June 18, 2019
Molecular Neuropathology in Practice: Clinical Profiling and Integrative Analysis of Molecular Alterations in GlioblastomaMacLean P Nasrallah, Zev A Binder, Derek A Oldridge, et al.
Pageof 7

Showing results (21-30 of 70) with videos related to

Sort By:
Pageof 7
Neuro-Oncology|September 20, 2022
EGFR, the Lazarus target for precision oncology in glioblastomaBenjamin Lin, Julia Ziebro, Erin Smithberger, et al.
Nature Cancer|February 5, 2022
Targeting PAK4 to reprogram the vascular microenvironment and improve CAR-T immunotherapy for glioblastomaWenjuan Ma, Yanling Wang, Rongxin Zhang, et al.
Scientific Reports|March 25, 2018
Radiomic MRI signature reveals three distinct subtypes of glioblastoma with different clinical and molecular characteristics, offering prognostic value beyond IDH1Saima Rathore, Hamed Akbari, Martin Rozycki, et al.
Molecular Therapy Oncolytics|December 2, 2022
The IAP antagonist birinapant enhances chimeric antigen receptor T cell therapy for glioblastoma by overcoming antigen heterogeneityEdward Z Song, Xin Wang, Benjamin I Philipson, et al.
Research in Veterinary Science|December 31, 2020
Pathology of macrophage activation syndrome in humanized NSGS miceJames C Tarrant, Zev A Binder, Mattia Bugatti, et al.
Journal of Neuro-Oncology|September 23, 2019
Negative prognostic impact of epidermal growth factor receptor copy number gain in young adults with isocitrate dehydrogenase wild-type glioblastomaDaniel I Hoffman, Kalil G Abdullah, Makayla McCoskey, et al.
Cancer Immunology Research|May 4, 2022
Immunologic Features in De Novo and Recurrent Glioblastoma Are Associated with Survival OutcomesCécile Alanio, Zev A Binder, Renee B Chang, et al.
Science Translational Medicine|February 28, 2020
Wnt-mediated endothelial transformation into mesenchymal stem cell-like cells induces chemoresistance in glioblastomaMenggui Huang, Duo Zhang, Janet Y Wu, et al.
SLAS Technology|October 6, 2018
Mutation Profiles in Glioblastoma 3D Oncospheres Modulate Drug EfficacyKelli M Wilson, Lesley A Mathews-Griner, Tara Williamson, et al.
Academic Pathology|June 18, 2019
Molecular Neuropathology in Practice: Clinical Profiling and Integrative Analysis of Molecular Alterations in GlioblastomaMacLean P Nasrallah, Zev A Binder, Derek A Oldridge, et al.
Pageof 7